1-Deoxynojirimycin pretreatment attenuates LPS-induced acute lung injury and is associated with gut microbial and serum metabolic changes in mice
Frontiers in Pharmacology · 18.11.2026 · 17
DOI: 10.3389/fphar.2026.1975885 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 18.11.2026. Verfasst von Pinglin Zhang und 4 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
In this study, we evaluated whether 7-day pretreatment with 1-DNJ, a characteristic plant metabolite found in Morus alba leaves, reduced susceptibility to LPS-induced ALI in mice, and integrated 16S rRNA sequencing and serum metabolomics to explore gut microbiota-related host responses associated with this protection.
Methods
C57BL/6 mice received 1-DNJ for 7 days before intratracheal LPS challenge. We assessed lung pathology, ultrastructural injury, edema, alveolar barrier leakage and inflammatory-cell recruitment using histological, biochemical and cellular readouts. Cytokine profiles in BALF were quantified with a Bio-Plex assay. Gut microbial changes and serum metabolic alterations were assessed by 16S rRNA sequencing and untargeted metabolomics. Lung COX-2 expression and p38 MAPK phosphorylation were further examined by Western blotting and immunofluorescence.
Results
1-DNJ lessened fluid accumulation, alveolar barrier dysfunction and inflammatory-cell influx, with parallel reductions in BALF IL-6, IL-1β, TNF-α, KC, MCP-1 and RANTES in LPS-induced ALI. 1-DNJ also reshaped LPS-associated gut dysbiosis by restoring Phascolarctobacterium and Prevotellaceae_UCG-001 while reducing inflammation-associated genera, particularly Helicobacter, Ruminiclostridium_9, Oscillibacter and Tyzzerella _3. Untargeted serum metabolomic profiling revealed changes in features putatively annotated as prostaglandin E2, 15-HETE, tryptophan, indole derivatives, adenosine and acylcarnitines. Correlation analysis linked lung injury indices, inflammatory mediators, bacterial genera and circulating metabolites. Western blot and immunofluorescence further showed that 1-DNJ suppressed LPS-induced COX-2 expression and p38 MAPK phosphorylation.
Discussion
Collectively, these findings suggest that prophylactic 1-DNJ administration may reduce susceptibility to LPS-induced ALI, in association with stabilization of gut microbiota-related metabolic and inflammatory responses.
Zitieren
APA
Zhang, P., He, Q., Su, L., Jiang, R., & Yang, Y. (2026). 1-Deoxynojirimycin pretreatment attenuates LPS-induced acute lung injury and is associated with gut microbial and serum metabolic changes in mice. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1975885
Vancouver
Zhang P, He Q, Su L, Jiang R, Yang Y. 1-Deoxynojirimycin pretreatment attenuates LPS-induced acute lung injury and is associated with gut microbial and serum metabolic changes in mice. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1975885
BibTeX
@article{Zhang2026,
author = {Zhang, Pinglin and He, Qing and Su, Lijun and Jiang, Ruyong and Yang, Yi},
title = {1-Deoxynojirimycin pretreatment attenuates LPS-induced acute lung injury and is associated with gut microbial and serum metabolic changes in mice},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1975885}
}
EUVIMED